Schedule

Print

The schedule for the 2017 program is below. 2019 schedule not yet available.

Sunday · April 30, 2017
6:30am to 7:45am Registration and Breakfast
7:45am to 8:00am Seating
8:00am to 8:15am Welcome, Introductions, Course Objectives

Samuel Z. Goldhaber, MD; Peter Libby, MD; Patrick O'Gara, MD; Calum MacRae, MD, PhD

Atherosclerosis, Inflammation, Thrombosis, and Risk Factors

Co-Chairs: Samuel Z. Goldhaber, MD and Patrick O'Gara, MD

8:15am to 8:50am Pathophysiology of Acute Myocardial Infarction: Review of Plaque Rupture; New Insights into Superficial Erosion; Correlation of Pathophysiology with Patient Profile

Peter Libby, MD

8:50am to 9:00am Discussion, Q&A
9:00am to 9:35am Targeting and Reducing Inflammation in Atherothrombosis: JUPITER, CANTOS, and CIRT Trials

Paul M Ridker, MD, MPH

9:35am to 9:45am Discussion, Q&A
9:45am to 10:20am Rapid-Fire Lipid Disorder Cases: Low HDL, High Triglycerides, Lack of Statin Adherence, PCSK9 Inhibitors

Jorge Plutzky, MD

10:20am to 10:30am Discussion, Q&A
10:30am to 10:50am Coffee Break

Refreshments provided

Thomas W. Smith, MD Memorial Lecture

Session Chair: Peter Libby, MD

10:50am to 11:40am Diabetic Cardiomyopathy: Foxglove, FoxO, and Failure

Joseph A. Hill, MD, PhD

11:40am to 11:50am Discussion, Q&A
11:50am to 1:00pm Lunch Break

Valvular Heart Disease Symposium

Session Chair: Deepak L. Bhatt, MD, MPH

1:00pm to 1:35pm Mitral Valve Disease: Hemodynamics, Clinical Assessment, and Guidelines

Patrick O'Gara, MD

1:35pm to 1:45pm Discussion, Q&A
1:45pm to 2:20pm Transcatheter Aortic and Mitral Valve Therapies

Pinak B. Shah, MD

2:20pm to 2:30pm Discussion, Q&A

Eugene Braunwald, MD Lecture

Session Chair: Patrick O’Gara, MD

2:30pm to 3:10pm Congestive Heart Failure: The Past, the Present, and the Future

Eugene Braunwald, MD

3:10pm to 3:20pm Discussion, Q&A
3:20pm to 3:40pm Snack Break

Refreshments provided

Atrial Fibrillation

Session Chair: Laurence M. Epstein, MD

3:40pm to 4:15pm Stroke Prevention in Atrial Fibrillation: Warfarin, Antiplatelet Therapy, and Novel Oral Anticoagulants: Where Do We Stand? Has the Dust Settled?

Christian T. Ruff, MD, MPH

4:15pm to 4:25pm Discussion, Q&A
4:25pm to 5:00pm Atrial Fibrillation: Rate versus Rhythm Control, Antiarrhythmic Therapy, Ablation, and Left Atrial Appendage Occlusion

Gregory Michaud, MD

5:00pm to 5:10pm Discussion, Q&A
5:10pm to 5:45pm The Genetics of Atrial Fibrillation

Calum A. MacRae, MD, PhD

5:45pm to 5:55pm Discussion, Q&A
Monday · May 1, 2017

Congenital Heart Disease, Pulmonary Embolism, Pulmonary Hypertension, and Systemic Arterial Hypertension

Session Chair: Samuel Z. Goldhaber, MD

8:00am to 8:35am Management of Pulmonary Embolism & Deep Vein Thrombosis: Pathophysiology, Risk Stratification, Novel Oral Anticoagulants, Thrombolytic Therapy, Pharmacomechanical Therapy in the Cath Lab, Surgical Embolectomy, Options for Extended Duration Anticoagulation

Samuel Z. Goldhaber, MD

8:35am to 8:45am Discussion, Q&A
8:45am to 9:20am Right Heart Failure Due to Congenital Heart Disease: Several Case-Based Presentations

Michael J. Landzberg, MD

9:20am to 9:30am Discussion, Q&A
9:30am to 10:05am Pulmonary Hypertension: Classification, Diagnosis, and Emerging Therapies

Aaron B. Waxman, MD, PhD

10:05am to 10:15am Discussion, Q&A
10:15am to 10:40am Coffee Break

Refreshments provided

10:40am to 11:15am Systemic Arterial Hypertension: What Drugs and What Parameters Should We Use for Blood Pressure Control?

Susan Cheng, MD

11:15am to 11:25am Discussion, Q&A

Featured Presentation: Department of Medicine Chair's Lecture

Session Chair: Calum A. MacRae, MD, PhD

11:25am to 12:00pm Precision Cardiovascular Medicine: Case Study of a Patient with Premature Atherothrombosis—Bedside-to-Bench Analysis and Bench-to-Bedside Implications for Care

Joseph Loscalzo, MD, PhD

12:00pm to 12:10pm Discussion, Q&A
12:10pm to 1:20pm Lunch Break

Intersection of Cardiovascular Medicine, Internal Medicine, and High-Risk Obstetrics

Session Chairs: Samuel Z. Goldhaber, MD and Patrick O'Gara, MD

1:20pm to 1:55pm What the General Cardiologist Needs to Know about Amyloidosis

Rodney H. Falk, MD

1:55pm to 2:05pm Discussion, Q&A
2:05pm to 2:40pm Pericardial Disease: Etiology, Anti-Inflammatory Therapy, Duration of Therapy, Use of Colchicine, and Tips on Weaning from Prednisone

Leonard S. Lilly, MD

2:40pm to 2:50pm Discussion, Q&A
2:50pm to 3:25pm Cardiovascular Management of High-Risk Pregnancy

Anne Marie Valente, MD

3:25pm to 3:35pm Discussion, Q&A
3:35pm to 3:50pm Snack Break and Transition to Breakout Sessions

Refreshments provided

Breakout Sessions I, II, III

Program participants will have the opportunity to attend all three breakout sessions

3:50pm to 4:40pm Breakout Sessions I, II, III

Session I: Rapid-Fire ECG Quiz
Philip J. Podrid, MD
Session II: Case-Based Stroke Prevention in Atrial Fibrillation
Christian T. Ruff, MD, MPH
Session III: Case-Based Geriatric Cardiology Conundrums
Susan Cheng, MD

4:40pm to 4:50pm Transition
4:50pm to 5:40pm Breakout Sessions I, II, III

Session I: Rapid-Fire ECG Quiz
Philip J. Podrid, MD
Session II: Case-Based Stroke Prevention in Atrial Fibrillation
Christian T. Ruff, MD, MPH
Session III: Case-Based Geriatric Cardiology Conundrums
Susan Cheng, MD

5:40pm to 5:50pm Transition
5:50pm to 6:40pm Breakout Sessions I, II, III

Session I: Rapid-Fire ECG Quiz
Philip J. Podrid, MD
Session II: Case-Based Stroke Prevention in Atrial Fibrillation
Christian T. Ruff, MD, MPH
Session III: Case-Based Geriatric Cardiology Conundrums
Susan Cheng, MD

Tuesday · May 2, 2017

Electrophysiology

Co-Chairs: Laurence M. Epstein, MD and William G. Stevenson, MD

8:00am to 8:35am EP Device and Lead Management Principles for the General Cardiologist and Internist

Laurence M. Epstein, MD

8:35am to 8:45am Discussion, Q&A
8:45am to 9:20am Ventricular Tachycardia Storm And Other EP Emergencies: A Case-Based Approach to Management

William G. Stevenson, MD

9:20am to 9:30am Discussion, Q&A
9:30am to 10:05am Rapid-Fire Case-Based Arrhythmia Quiz

Laurence M. Epstein, MD

10:05am to 10:15am Discussion, Q&A
10:15am to 10:40am Coffee Break

Refreshments provided

Multimodality Cardiovascular Imaging

Co-Chairs: Donna M. Polk, MD, MPH and Ron Blankstein, MD

10:40am to 11:15am Rapid-Fire Echocardiography Cases, including Diastolic Dysfunction, ECHO-Contrast, and Transesophageal ECHO

Donna M. Polk, MD, MPH

11:15am to 11:25am Discussion, Q&A
11:25am to 12:00pm How to Select, Use, and Integrate the Results of Cardiovascular Imaging Tests: CT, Magnetic Resonance, and Nuclear Imaging

Ron Blankstein, MD

12:00pm to 12:10pm Discussion, Q&A
12:10pm to 1:20pm Lunch Break

Intersection of Cardiovascular and Internal Medicine

Session Chairs: Samuel Z. Goldhaber, MD and Peter Libby, MD

1:20pm to 1:55pm Sleep-Disordered Breathing: Relationship to Heart Failure, Atrial Fibrillation, and Pulmonary Hypertension

Susan Redline, MD, MPH

1:55pm to 2:05pm Discussion, Q&A
2:05pm to 2:40pm What Cardiovascular Specialists Need to Know about Diabetes Mellitus

Enrico Cagliero, MD

2:40pm to 2:50pm Discussion, Q&A
2:50pm to 3:00pm Transition to Breakout Sessions

Breakout Sessions IV, V, VI

Program participants will have the opportunity to attend all three breakout sessions

3:00pm to 3:50pm Breakout Sessions IV, V, VI

Session IV: Bleeding and Clotting Cases
Gregory Piazza, MD
Session V: Difficult Dilemmas That My Patients and I Have Confronted
Part I

Patrick O’Gara, MD
Session VI: Rapid-Fire Cases from the Vascular Diagnostic Laboratory
Piotr Sobieszczyk, MD

3:50pm to 4:00pm Transition
4:00pm to 4:50pm Breakout Sessions IV, V, VI

Session IV: Bleeding and Clotting Cases
Gregory Piazza, MD
Session V: Difficult Dilemmas That My Patients and I Have Confronted
Part I

Patrick O’Gara, MD
Session VI: Rapid-Fire Cases from the Vascular Diagnostic Laboratory
Piotr Sobieszczyk, MD

4:50pm to 5:00pm Transition
5:00pm to 5:50pm Breakout Sessions IV, V, VI

Session IV: Bleeding and Clotting Cases
Gregory Piazza, MD
Session V: Difficult Dilemmas That My Patients and I Have Confronted
Part I

Patrick O’Gara, MD
Session VI: Rapid-Fire Cases from the Vascular Diagnostic Laboratory
Piotr Sobieszczyk, MD

Wednesday · May 3, 2017

Acute Coronary Syndromes

Session Chair: Samuel Z. Goldhaber, MD

8:00am to 8:35am Acute Coronary Syndromes: Guideline Updates and Novel, Emerging Therapies

Elliott M. Antman, MD

8:35am to 8:45am Discussion, Q&A

Cardiohematology

Session Chairs: Samuel Z. Goldhaber, MD and Jean M. Connors, MD

8:45am to 9:20am Heparin Monitoring: PTT, ACT, Anti-XA, TEG Which Strategy is Best for the General Cardiologist?

Jean M. Connors, MD

9:20am to 9:30am Discussion, Q&A
9:30am to 10:05am Triple Therapy with Anticoagulation Plus Dual Antiplatelet TherapyWhat Duration of Dual Antiplatelet Therapy? Which Antiplatelet Agents Should We Select? Is There a Role for Proton Pump Inhibitors?

Deepak L. Bhatt, MD, MPH

10:05am to 10:15am Discussion, Q&A
10:15am to 10:40am Coffee Break

Refreshments provided

10:40am to 11:15am NOACs: Randomized Trials versus Real World Evidence for Safety and Efficacy, Management of Bleeding Complications, and Role of Antidotes

Samuel Z. Goldhaber, MD

11:15am to 11:25am Discussion, Q&A

Kenneth L. Baughman, MD Memorial Lecture

Session Chair: Patrick O'Gara, MD

11:25am to 12:15pm Cardiovascular Safety in Athletes

Aaron L. Baggish, MD

12:15pm to 12:25pm Discussion, Q&A
12:25pm to 1:35pm Lunch Break

State-of-the-Art Lectures

Session Chairs: Samuel Z. Goldhaber, MD and Peter Libby, MD

1:35pm to 2:10pm Challenges for Cardiac Intensive Care: Cooling Protocols, Ventilator Settings, Extracorporeal Membrane Oxygenation, Resuscitation Science

Benjamin M. Scirica, MD

2:10pm to 2:20pm Discussion, Q&A
2:20pm to 2:55pm Novel Ways to Reduce Cardiovascular Risk: Bariatric Surgery and Treatment of Metabolic Syndrome

Deepak L. Bhatt, MD, MPH

2:55pm to 3:05pm Discussion, Q&A
3:05pm to 3:20pm Transition to Breakout Sessions

Breakout Sessions VII, VIII, IX

Program participants will have the opportunity to attend all three breakout sessions

3:20pm to 4:10pm Breakout Sessions VII, VIII, IX

Session VII: Cardiac Intensive Care Unit Cases
Benjamin M. Scirica, MD
Session VIII: Cardio-Oncology Cases
Anju Nohria, MD
Session IX: Difficult Dilemmas That My Patients and I Have Confronted - Part II
Patrick O’Gara, MD

4:10pm to 4:20pm Transition
4:20pm to 5:10pm Breakout Sessions VII, VIII, IX

Session VII: Cardiac Intensive Care Unit Cases
Benjamin M. Scirica, MD
Session VIII: Cardio-Oncology Cases
Anju Nohria, MD
Session IX: Difficult Dilemmas That My Patients and I Have Confronted - Part II
Patrick O’Gara, MD

5:10pm to 5:20pm Transition
5:20pm to 6:10pm Breakout SessionsVII, VIII, IX

Session VII: Cardiac Intensive Care Unit Cases
Benjamin M. Scirica, MD
Session VIII: Cardio-Oncology Cases
Anju Nohria, MD
Session IX: Difficult Dilemmas That My Patients and I Have Confronted - Part II
Patrick O’Gara, MD

Thursday · May 4, 2017

Advanced Heart Failure and Cardiomyopathy

Session Chair: Mandeep R. Mehra, MD

8:00am to 8:35am Advanced Heart Failure: State of the Art, including Mechanical Circulatory Support

Mandeep R. Mehra, MD

8:35am to 8:45am Discussion, Q&A
8:45am to 9:20am Optimizing Medical Therapy of Hospitalized Patients with Advanced Heart Failure: Tricks of the Trade

Garrick C. Stewart, MD

9:20am to 9:30am Discussion, Q&A
9:30am to 10:05am Preventing Readmission of Advanced Heart Failure Patients within 30 Days of Discharge: Optimizing Disease Management with Implementation Science and Therapies such as CardioMEMS and Entresto

Akshay S. Desai, MD, MPH

10:05am to 10:15am Discussion, Q&A
10:15am to 10:40am Coffee Break

Refreshments provided

10:40am to 11:15am Clinical Importance of Assessing Quality of Life in Advanced Heart Failure Patients: Correlation with Prognosis and Association with Socioeconomic and Racial/ Ethnic/ Cultural Considerations

Eldrin F. Lewis, MD, MPH

11:15am to 11:25am Discussion, Q&A

Cath Lab Revascularization of Acute MI: Change in Philosophy regarding Extent of Revascularization?

Session Chair: Gregory Piazza, MD, MS

11:25am to 12:00pm Acute Coronary Syndromes: Revascularization in the Cardiac Cath Lab Culprit Artery Only or Complete Revascularization?

Laura Mauri, MD, MS

12:00pm to 12:10pm Discussion, Q&A

Vascular Medicine

Co-Chairs: Samuel Z. Goldhaber, MD and Gregory Piazza, MD, MS

12:10pm to 12:45pm Vasculitis, including Takayasu’s Arteritis, Giant Cell Arteritis, Thromboangiitis Obliterans (Buerger’s Disease), and Kawasaki Disease in the Adult

Gregory Piazza, MD, MS

12:45pm to 12:55pm Discussion, Q&A
12:55pm to 1:55pm Lunch Break
1:55pm to 2:30pm ‘Code Aorta’: How to Organize a Strategic Multidisciplinary Response to a Potentially Fatal Vascular Emergency? Initial Results and Rapid-Fire Case Presentations

Marc P. Bonaca, MD, MPH

2:30pm to 2:40pm Discussion, Q&A
2:40pm to 3:15pm Peripheral Arterial Disease: Pathophysiology, Intermittent Claudication, and Critical Limb Ischemia

Gregory Piazza, MD, MS

3:15pm to 3:25pm Discussion, Q&A
3:25pm to 4:00pm Cardiovascular Benefits and Risks of Anti-Diabetic Drugs

Marc A. Pfeffer, MD, PhD

4:00pm to 4:10pm Discussion, Q&A
4:10pm to 4:45pm Ongoing Potential Practice-Changing Trials in Pulmonary Embolism and Deep Vein Thrombosis: Do You Worship at the Altar of P < 0.05?

Samuel Z. Goldhaber, MD

4:45pm to 4:55pm Discussion, Q&A
4:55pm to 5:00pm General Discussion, Wrap-up
5:00pm Course Adjourns